These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24364093)

  • 1. [The immunological mechanisms contributing to the clinical efficacy of allergen specific immunotherapy (SIT) in allergic diseases].
    Asher I; Mahlab-Guri K; Sthoeger Z
    Harefuah; 2013 Sep; 152(9):529-33, 564, 563. PubMed ID: 24364093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T regulatory cells in allergen-specific immunotherapy.
    Verhagen J; Taylor A; Blaser K; Akdis M; Akdis CA
    Int Rev Immunol; 2005; 24(5-6):533-48. PubMed ID: 16318994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.
    Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA
    Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
    Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
    Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological mechanisms of allergen-specific immunotherapy.
    Jutel M; Akdis CA
    Allergy; 2011 Jun; 66(6):725-32. PubMed ID: 21466562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects: Galectin-1 and specific immunotherapy for allergic responses in the intestine.
    Yang LT; Shu Q; Luo XQ; Liu ZQ; Qiu SQ; Liu JQ; Guo HJ; Li LJ; Li MG; Liu DB; Xia LX; Liu ZG; Yang PC
    Allergy; 2018 Jan; 73(1):106-114. PubMed ID: 28718965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
    Rolland JM; Prickett S; Gardner LM; O'Hehir RE
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.
    Verhagen J; Blaser K; Akdis CA; Akdis M
    Immunol Allergy Clin North Am; 2006 May; 26(2):207-31, vi. PubMed ID: 16701141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of allergen-specific antibodies in allergy and specific immunotherapy.
    Blaser K; Akdis CA; Faith A
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):243-51; discussion 252. PubMed ID: 11487881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy.
    Frew AJ
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory cells in allergen-specific immunotherapy.
    Soyka MB; Holzmann D; Akdis CA
    Immunotherapy; 2012 Apr; 4(4):389-96. PubMed ID: 22512633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy.
    Lou W; Wang C; Wang Y; Han D; Zhang L
    Int Arch Allergy Immunol; 2012; 159(4):391-8. PubMed ID: 22846686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-specific immunotherapy.
    Nelson HS; Norman PS
    Chem Immunol Allergy; 2014; 100():333-8. PubMed ID: 24925414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy.
    Bohle B
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):233-41. PubMed ID: 12371619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells.
    Akdis CA; Akdis M
    J Allergy Clin Immunol; 2009 Apr; 123(4):735-46; quiz 747-8. PubMed ID: 19348912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.